Elsevier

The Journal of Pain

Volume 16, Issue 1, January 2015, Pages 3-10
The Journal of Pain

Critical Review
Data Interpretation in Analgesic Clinical Trials With Statistically Nonsignificant Primary Analyses: An ACTTION Systematic Review

https://doi.org/10.1016/j.jpain.2014.10.003Get rights and content
Under an Elsevier user license
open archive

Highlights

  • We investigated spin in RCTs with nonsignificant primary analyses.

  • Authors and editors should prioritize transparent reporting of RCTs.

  • Transparent reporting includes unbiased interpretation and recognizing limitations.

Abstract

Peer-reviewed publications of randomized clinical trials (RCTs) are the primary means of disseminating research findings. “Spin” in RCT publications is misrepresentation of statistically nonsignificant research findings to suggest treatment benefit. Spin can influence the way readers interpret clinical trials and use the information to make decisions about treatments and medical policies. The objective of this study was to determine the frequency with which 4 types of spin were used in publications of analgesic RCTs with nonsignificant primary analyses in 6 major pain journals. In the 76 articles included in our sample, 28% of the abstracts and 29% of the main texts emphasized secondary analyses with P values <.05; 22% of abstracts and 29% of texts emphasized treatment benefit based on nonsignificant primary results; 14% of abstracts and 18% of texts emphasized within-group improvements over time, rather than primary between-group comparisons; and 13% of abstracts and 10% of texts interpreted a nonsignificant difference between groups in a superiority study as comparable effectiveness. When considering the article conclusion sections, 21% did not mention the nonsignificant primary result, 22% were presented with no uncertainty or qualification, 30% did not acknowledge that future research was required, and 8% recommended the intervention for clinical use.

Perspective

This article identifies relatively frequent “spin” in analgesic RCTs. These findings highlight a need for authors, reviewers, and editors to be more cognizant of how analgesic RCT results are presented and attempt to minimize spin in future clinical trial publications.

Key words

Spin
misrepresentation
randomized clinical trials
ACTTION
systematic review

Cited by (0)

The work was performed at the University of Rochester, Rochester, New York.

The manuscript was reviewed and approved by the Executive Committee of the ACTTION public-private partnership with the United States Food and Drug Administration.

The views expressed in this article are those of the authors and no official endorsement by the Food and Drug Administration (FDA) or the pharmaceutical companies that provided unrestricted grants to support the activities of the Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) public-private partnership should be inferred. Financial support for this project was provided by the ACTTION public-private partnership, which has received research contracts, grants, or other revenue from the FDA (U01 FD004187), Annovation, Astellas, Collegium, Depomed, Jazz, Johnson & Johnson, Lilly, Olatec, Pfizer, Purdue, Spinifex, and Teva. None of the authors have financial disclosures that are relevant to this article.

Supplementary data accompanying this article are available online at www.jpain.org and www.sciencedirect.com.